Alpha-amylase and Alpha-glucosidase Inhibitory Activities of Philippine Indigenous Medicinal Plants

Author:

Tulin Edgardo E.,Atok Jo Jane D.,Tulin Anabella B.,Vergara April Joy S.,Loreto Ma. Theresa P.

Abstract

In the Philippines, medicinal plants still provide the first line of therapeutic remedies and their reported efficacy in traditional treatments provides an opportunity for drug discovery and development. The study aimed to evaluate in vitro commonly used Philippine medicinal plants for their alpha-amylase and alpha-glucosidase inhibitory activities as potential sources of antidiabetic agents. The study emphasised the inhibitory activities of 54 medicinal plants against α-amylase and α-glucosidase enzymes. The findings revealed 7 medicinal plants with the highest alpha-glucosidase inhibitory activity of ≥ 50% and 3 with alpha-amylase inhibitory activity of ≥ 20%. Ethyl acetate extract of Cycas sp. exhibited the highest α-glucosidase inhibitory activity with 83.87% ± 1.52 followed by the aqueous extract of cf. Calyptranthera sp. With 82.07% ± 0.14 with Acarbose as the reference standard (99.71% ± 0.63) at 10µg/mL (w/v) concentration. For the alpha-amylase inhibitory assay, the highest bioactivity was observed in ethyl acetate extract of Curcuma longa L. (39.44% ± 1.56) with Acarbose as the reference standard (51.59% ± 0.98) at 10µg/mL (w/v) concentration. These findings suggest the potential of the above-mentioned plants as sources of alpha-amylase and alpha-glucosidase inhibitors that may be used as antidiabetic agents.

Publisher

Informatics Publishing Limited

Reference24 articles.

1. Ahmad LA, Crandall JP. Type 2 diabetes prevention: A review. Clin iabetes. 2010; 28(2):53-9. Available from: https://diabetesjournals.org/clinical/article/28/2/53/31277/Type-2-Diabetes-Prevention-A-Review https://doi.org/10.2337/diaclin.28.2.53

2. Mohan V, Venkatraman JV, Pradeepa R. Epidemiology of cardiovascular disease in type 2 diabetes: The Indian scenario. J Diabetes Sci Technol. 2010; 4(1):158-70. Available from: http://journals.sagepub.com/doi/10.1177/193229681000400121 https://doi.org/10.1177/193229681000400121 PMid:20167181 PMCid: PMC2825638. 3.

3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019; 157:107843. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168822719312306 https://doi.org/10.1016/j.diabres.2019.107843 PMid:31518657.

4. Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne) (Internet). 2017; p. 8. Available from: http://journal.frontiersin.org/article/10.3389/fendo.2017.00006/full https://doiorg/10.3389/fendo.2017.00006 PMid:28167928 PMCid: PMC5256065.

5. Ma J-T, Li D-W, Liu J-K, He J. Advances in research on chemical constituents and their biological activities of the Genus Actinidia. Nat Products Bioprospect. 2021; 11(6):573-609. Available from: https://link.springer.com/10.1007/s13659-021-00319-8 https://doi.org/10.1007/s13659-021-00319-8 PMid:34595735 PMCid: PMC8599787.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3